Status: Recruiting
HS235 Study in Overweight and Obese Participants With Combined Pre and Post-Capillary Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction
Study of HS235 in Overweight and Obese Participants with Combined Pre and Post-Capillary Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction
Participants needed: 126
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: 35Pharma IncUpdated: Sep 29, 2026Locations: 2
Eligibility criteria
Male or female, ≥ 18 years of age. [+16]
Hospitalization for any worsening medical condition or major surgery within 4 we... [+9]